APA (7th ed.) Citation

Mackenzie, I. S., Rogers, A., Poulter, N. R., Williams, B., Brown, M. J., Webb, D. J., . . . MacDonald, T. M. (2022). Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): A prospective, randomised, open-label, blinded-endpoint clinical trial. The Lancet (British edition), 400(10361), 1417-1425. https://doi.org/10.1016/S0140-6736(22)01786-X

Chicago Style (17th ed.) Citation

Mackenzie, Isla S., et al. "Cardiovascular Outcomes in Adults with Hypertension with Evening Versus Morning Dosing of Usual Antihypertensives in the UK (TIME Study): A Prospective, Randomised, Open-label, Blinded-endpoint Clinical Trial." The Lancet (British Edition) 400, no. 10361 (2022): 1417-1425. https://doi.org/10.1016/S0140-6736(22)01786-X.

MLA (9th ed.) Citation

Mackenzie, Isla S., et al. "Cardiovascular Outcomes in Adults with Hypertension with Evening Versus Morning Dosing of Usual Antihypertensives in the UK (TIME Study): A Prospective, Randomised, Open-label, Blinded-endpoint Clinical Trial." The Lancet (British Edition), vol. 400, no. 10361, 2022, pp. 1417-1425, https://doi.org/10.1016/S0140-6736(22)01786-X.